Ignite Creation Date:
2024-05-06 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05213143
Status:
TERMINATED
Last Update Posted:
2024-04-19
First Post:
2021-12-05
Brief Title:
The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
Sponsor:
Sumitomo Pharma Suzhou Co Ltd
Organization:
Sumitomo Pharma Suzhou Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-18
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-05
First Submit QC Date:
January 16 2022
Study First Post Date:
2022-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-17
Last Update Post Date:
2024-04-19
Last Update Post Date Type:
ACTUAL